Capital Rx has filed a notice of an exempt offering of securities to raise $312,497,075.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Capital Rx is raising up to $312,497,075.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Anthony Loiacono played a…